Upadacitinib for Treatment of Granulomatous Cheilitis.

De Greef A, Peeters C, Dewit O, de Montjoye L, Baeck M

DOI: 10.1001/jamadermatol.2024.2378
Published: 2024 Sep 1
Container: JAMA dermatology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamadermatol.2024.2378,
  title = {Upadacitinib for Treatment of Granulomatous Cheilitis.},
  author = {De Greef A and Peeters C and Dewit O and de Montjoye L and Baeck M},
  year = {2024},
  journal = {JAMA dermatology},
  doi = {10.1001/jamadermatol.2024.2378},
  url = {https://doi.org/10.1001/jamadermatol.2024.2378}
}

RIS

TY  - JOUR
TI  - Upadacitinib for Treatment of Granulomatous Cheilitis.
AU  - De Greef A
AU  - Peeters C
AU  - Dewit O
AU  - de Montjoye L
AU  - Baeck M
PY  - 2024
JO  - JAMA dermatology
DO  - 10.1001/jamadermatol.2024.2378
UR  - https://doi.org/10.1001/jamadermatol.2024.2378
ER  -

APA

A, D. G., C, P., O, D., L, D. M., & M, B. (2024). Upadacitinib for Treatment of Granulomatous Cheilitis.. JAMA dermatology. https://doi.org/10.1001/jamadermatol.2024.2378

Source records

pubmed · retrieved 2026-11-10T13:19:59.792Z